Judge Offers Split Decision In AWP Claim Spat

Law360, New York (March 14, 2008, 12:00 AM EDT) -- A federal district judge has partially denied Abbott Laboratories' bid to dismiss fresh claims brought by the U.S. government, as the massive antitrust litigation that alleges a group of pharmaceutical giants conspired to artificially inflate prescription drugs prices continues to roll along.

U.S. District Judge Patti Saris on Thursday granted in part and denied in part the government's request for permission to amend its earlier complaint-in-intervention against the pharmaceutical giant.

“The motion to amend is permitted to the extent it seeks to add timely claims involving...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.